申请人:Takeda Chemical Industries, Ltd.
公开号:EP0155845A1
公开(公告)日:1985-09-25
Thiazolidinedione derivatives of the general formula:
[wherein R1 and R2 are the same or different and each represent hydrogen or a lower alkyl group; R3 is hydrogen or an acyl group; n is 0 or 1] and salts thereof are novel compounds, which exhibit in mammals blood sugar- and lipid-lowering activity, and are of value as a therapuetic agent for diabetes and therapeutic agent for hyperlipemia.
通式为:[其中 R1 和 R2 相同或不同,各自代表氢或低级烷基;R3 为氢或酰基;n 为 0 或 1]的噻唑烷二酮衍生物及其盐类是新型化合物,在哺乳动物体内具有降血糖和降血脂活性,具有糖尿病治疗剂和高血脂治疗剂的价值。